Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
LGND > SEC Filings for LGND > Form 8-K on 12-Apr-2013All Recent SEC Filings

Show all filings for LIGAND PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro



Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Effective April 9, 2013, the board of directors (the "Board") of Ligand Pharmaceuticals Incorporated (the "Company") amended and restated the bylaws of the Company (the "Second Amended and Restated Bylaws" or "Bylaws") in order to provide for, among other things, the following: (i) to allow the Board to determine that a stockholder meeting may be held by means of remote communication; (ii) to allow notice to be given to stockholders by electronic transmissions (by fax, e-mail, posting to an electronic network, or any other form of electronic transmission) if consented to by the stockholder to whom notice is being given; and (iii) to allow waiver of notice to be given by stockholders by electronic transmissions by the person entitled to notice. The foregoing description of the Second Amended and Restated Bylaws is qualified in its entirety by the text of the Second Amended and Restated Bylaws, which are filed as Exhibit 3.1 to this Current Report on Form 8-K and are incorporated by reference in their entirety into this Item 5.03. Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.      Description

3.1              Second Amended and Restated Bylaws of Ligand Pharmaceuticals


  Add LGND to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for LGND - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.